Association of Impaired Fasting Glucose With Cardiovascular Disease in the Absence of Risk Factor

被引:10
作者
Zuo, Yingting [1 ,2 ,3 ,4 ]
Han, Xinsheng [5 ]
Tian, Xue [1 ,2 ,3 ,4 ]
Chen, Shuohua [6 ]
Wu, Shouling [6 ]
Wang, Anxin [1 ,2 ]
机构
[1] Capital Med Univ, Beijing Tiantan Hosp, China Natl Clin Res Ctr Neurol Dis, 119 South 4th Ring West Rd, Beijing 100070, Peoples R China
[2] Capital Med Univ, Beijing Tiantan Hosp, Dept Neurol, Beijing, Peoples R China
[3] Capital Med Univ, Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Beijing, Peoples R China
[4] Beijing Municipal Key Lab Clin Epidemiol, Beijing, Peoples R China
[5] Kai Feng Cent Hosp, Dept Neurol, Kaifeng, Peoples R China
[6] North China Univ Sci & Technol, Kailuan Hosp, Dept Cardiol, 57 Xinhua East Rd, Tangshan 063000, Peoples R China
关键词
fasting plasma glucose; impaired fasting glucose; traditional ASCVD risk factors; cardiovascular disease; DIABETES-MELLITUS; SUBCLINICAL ATHEROSCLEROSIS; MYOCARDIAL-INFARCTION; PLASMA-GLUCOSE; BLOOD-PRESSURE; HYPERTENSION; PREVALENCE; METAANALYSIS; EVENTS; HEALTH;
D O I
10.1210/clinem/dgab809
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background The association between impaired fasting glucose and cardiovascular disease (CVD) in participants without atherosclerotic CVD (ASCVD) risk factors based on current definitions is unclear. The study aimed to examine the association of fasting glucose levels with CVD and its subtypes in persons without ASCVD risk factors. Methods This study included 38 297 participants [men 62.1%; mean age 47.9 (12.9) years] who were free of a history of CVD and absent of ASCVD risk factors and had a fasting plasma glucose (FPG) level between 70 to 125 mg/dL at baseline from Kailuan Study during 2006 and 2007. Participants were followed until new-onset CVD event, death, or December 31, 2017. Cox proportional hazards models were performed to evaluate the associations. Results During a median follow-up of 11.0 years (interquartile range 10.7-11.2 years), we observed 1217 incident CVD events. Compared with participants with FPG 70 to 99 mg/dL, the multivariable adjusted hazard ratios for CVD among participants with FPG 100 to 109 mg/dL and 110 to 125 mg/dL were 1.18 (95% CI 1.02-1.38) and 1.27 (95% CI 1.03-1.55), respectively. Multivariable-adjusted spline regression model showed a J-shaped association between FPG and the risk of CVD. Conclusions We found that among individuals without diabetes or other traditional ASCVD risk factors, there is an increased risk of incident CVD with increasing abnormal FPG levels. These results highlight the importance of primordial prevention for FPG level increases along with other traditional ASCVD risk factors.
引用
收藏
页码:E1710 / E1718
页数:9
相关论文
共 50 条
  • [41] Glucose: a continuous risk factor for cardiovascular disease
    Gerstein, HC
    [J]. DIABETIC MEDICINE, 1997, 14 (08) : S25 - S31
  • [42] Association of aortic pressures with fasting plasma glucose in patients with and without impaired fasting glucose
    Cay, Serkan
    Ozturk, Sezgin
    Biyikoglu, Senay Funda
    Atak, Ramazan
    Balbay, Yucel
    Aydogdu, Sinan
    [J]. BLOOD PRESSURE, 2008, 17 (03) : 164 - 169
  • [43] Association of serum metabolites with impaired fasting glucose/diabetes and traditional risk factors for metabolic disease in Chinese adults
    Wang, Siming
    Yu, Xue
    Zhang, Wenduo
    Ji, Fusui
    Wang, Mo
    Yang, Ruiyue
    Li, Hongxia
    Chen, Wenxiang
    Dong, Jun
    [J]. CLINICA CHIMICA ACTA, 2018, 487 : 60 - 65
  • [44] The Association of Patient Age with Cardiovascular Disease Risk Factor Treatment and Control in Diabetes
    Usha Subramanian
    Julie A. Schmittdiel
    Neha Gavin
    Ana Traylor
    Connie S. Uratsu
    Joeseph V. Selby
    Carol M. Mangione
    [J]. Journal of General Internal Medicine, 2009, 24 : 1049 - 1052
  • [45] The Association of Patient Age with Cardiovascular Disease Risk Factor Treatment and Control in Diabetes
    Subramanian, Usha
    Schmittdiel, Julie A.
    Gavin, Neha
    Traylor, Ana
    Uratsu, Connie S.
    Selby, Joeseph V.
    Mangione, Carol M.
    [J]. JOURNAL OF GENERAL INTERNAL MEDICINE, 2009, 24 (09) : 1049 - 1052
  • [46] Comparison of clinical characteristics of impaired fasting glucose with impaired glucose tolerance in a Korean population
    Kim, SW
    Jeong, IK
    Shin, CS
    Park, YS
    Park, DJ
    Park, KS
    Kim, SY
    Cho, BY
    Lee, HK
    [J]. DIABETES MELLITUS: RECENT ADVANCES FOR THE 21ST CENTURY, 2000, 1209 : 77 - 80
  • [47] Effects of Supervised Exercise on Gamma-Glutamyl Transferase Levels in Patients with Isolated Impaired Fasting Glucose and Those with Impaired Fasting Glucose Plus Impaired Glucose Tolerance
    Burtscher, M.
    Gatterer, H.
    Duennwald, T.
    Pesta, D.
    Faulhaber, M.
    Netzer, N.
    Koch, R.
    Koenig, K.
    Ulmer, H.
    [J]. EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2012, 120 (08) : 445 - 450
  • [48] Dysglycaemia in non-diabetic hypertensive patients: comparison of the impact of two different classifications of impaired fasting glucose on the cardiovascular risk profile
    Dell'Omo, G.
    Penno, G.
    Del Prato, S.
    Mariani, M.
    Pedrinelli, R.
    [J]. JOURNAL OF HUMAN HYPERTENSION, 2009, 23 (05) : 332 - 338
  • [49] Prediction model for the onset risk of impaired fasting glucose: a 10-year longitudinal retrospective cohort health check-up study
    Wang, Yuqi
    Wang, Liangxu
    Su, Yanli
    Zhong, Li
    Peng, Bin
    [J]. BMC ENDOCRINE DISORDERS, 2021, 21 (01)
  • [50] Glucose intolerance: is it a risk factor for cardiovascular disease in children with chronic kidney disease?
    Canpolat, Nur
    Caliskan, Salim
    Sever, Lale
    Guzeltas, Alper
    Kantarci, Fatih
    Candan, Cengiz
    Civilibal, Mahmut
    Kasapcopur, Ozgur
    Arisoy, Nil
    [J]. PEDIATRIC NEPHROLOGY, 2012, 27 (04) : 627 - 635